Diabetic Under 70 (Diabetics Below 70)

Completed

• Conditions: Hyperlipidemia; Diabetes; Atherosclerosis

• Registration Number: NCT00516204
• Lead Sponsor: AstraZeneca

Brief Summary

A screening project of diabetics with a very high cardiovascular risk (e.g. diabetes plus coronary heart disease) who already receive cholesterol-lowering therapy. Lipid profile and rate of patients who are treated to target (which is \<70mg/dl for such patients with very high risk) are screened. The doctors therapy decisions after the screening will be documented and 8-10 weeks later the lipid profile of each patient will be evaluated again. Our aim is to evaluate dosing habits, to evaluate how many patients are treated to their LDL-C target and to underline the importance of treating patients to their cholesterol targets.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-07
• Study First Submitted: 2007-08-14
• Study First Submitted QC: 2007-08-14
• Study First Posted: 2007-08-15
• Primary Completion: 2007-12
• Study Completion: 2007-12
• Status Verified: 2014-10
• Last Update Submitted: 2014-10-29
• Last Update Posted: 2014-10-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 685

Inclusion Criteria

• Diabetics with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PAVK, etc.) who already receive cholesterol-lowering therapy

Read More

Exclusion Criteria

• Diabetics w/o CVD; diabetics who do not receive cholesterol-lowering therapy

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cholesterol levels	After 4 weeks	Cholesterol levels from high risk patients after 4 weeks of cholesterol-lowering drug therapy under target values

Trial Locations

Locations (1)

Research Site; 🇦🇹 Vienna, Austria